Assignee
AIMM THERAPEUTICS BV
NL·9 granted patents·2 pending applications·0 citations·filing 2012–2017
Top patents by PatentIndex Score
11 records- 0164US2017009205A1Ex vivo antibody productionAIMM THERAPEUTICS BV·Filed 2014·Application pending·0 cites
- 0262US10017562B2RSV G protein specific antibodiesAIMM THERAPEUTICS BV·Filed 2017·Granted Jul 10, 2018·0 cites·17 claims
- 0357US10556963B2Means and methods for counteracting myeloproliferative or lymphoproliferative disordersAIMM THERAPEUTICS BV·Filed 2014·Granted Feb 11, 2020·0 cites·16 claims
- 0457US9718876B2RSV G protein specific antibodiesAIMM THERAPEUTICS BV·Filed 2012·Granted Aug 1, 2017·0 cites·1 claims
- 0555US10344076B2Means and methods for producing high affinity antibodiesAIMM THERAPEUTICS BV·Filed 2016·Granted Jul 9, 2019·0 cites·9 claims
- 0654US11136407B2Therapeutic anti-CD9 antibodyAIMM THERAPEUTICS BV·Filed 2017·Granted Oct 5, 2021·0 cites·31 claims
- 0750US9969795B2Means and methods for producing high affinity antibodiesAIMM THERAPEUTICS BV·Filed 2015·Granted May 15, 2018·0 cites·8 claims
- 0843US2017313766A1Influenza a virus specific antibodiesAIMM THERAPEUTICS BV·Filed 2017·Application pending·0 cites
- 0935US10611829B2Means and methods for producing stable antibodiesAIMM THERAPEUTICS BV·Filed 2015·Granted Apr 7, 2020·0 cites·10 claims
- 1034US10690658B2Means and methods for determining T cell recognitionAIMM THERAPEUTICS BV·Filed 2015·Granted Jun 23, 2020·0 cites·30 claims
- 1129US10435463B2Hepatitis C virus specific antibodyAIMM THERAPEUTICS BV·Filed 2015·Granted Oct 8, 2019·0 cites·7 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →